AMTD // AMTD IDEA Group each representing three hundred sixty (360) (Class A)
ANR <GO> NYSE RQD COCKPIT → CIK 0001769731 ↗ Financials • Finance: Consumer Services
$20.68 ▲ +0.38
(+1.85%)
MKT CAP: $33.0M • VOL: 2.0K
52W L $20 52W H $77
ROARABLE / RQD
C- • 59/100
PIOTROSKI
6 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$17
MEDIAN
$23
MEAN
$24
HIGH
$28
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE AMTD TAPE
AMTD // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $25.02 | $23.78 | 2025-02-14 | $18.82 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $26.06 | $24.40 | 2025-02-06 | $19.44 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $23.58 | $22.75 | 2025-01-29 | $19.85 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $21.09 | — | 2025-01-17 | $20.27 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $18.20 | $19.65 | 2025-01-09 | $18.41 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $24.61 | $21.51 | 2024-12-18 | $17.99 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $20.06 | $20.89 | 2024-12-04 | $19.23 | -4.3% | 48% | C |